Jiangxi Sanxin Medtec Co Ltd
Jiangxi Sanxin Medtec Co.,Ltd. engages in the research and development, manufacture, sale, and service of medical devices. The company offers infusion and cardiothoracic surgery products; and blood purification products, such as dialysate filter, dialysis indwelling needle, disposable biological protein glue dispenser, dialysis fluid filter, continuous blood purification pipeline and accessories,… Read more
Jiangxi Sanxin Medtec Co Ltd (300453) - Total Liabilities
Latest total liabilities as of September 2025: CN¥833.14 Million CNY
Based on the latest financial reports, Jiangxi Sanxin Medtec Co Ltd (300453) has total liabilities worth CN¥833.14 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jiangxi Sanxin Medtec Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Jiangxi Sanxin Medtec Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jiangxi Sanxin Medtec Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangxi Sanxin Medtec Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xianheng International Science & Technology Co Ltd
SHG:605056
|
China | CN¥1.35 Billion |
|
Vanjee Technology Co Ltd
SHE:300552
|
China | CN¥958.76 Million |
|
Cecep Environmental Protection Equipment Co Ltd
SHE:300140
|
China | CN¥16.01 Billion |
|
BASF India Limited
NSE:BASF
|
India | ₹38.85 Billion |
|
Zhejiang Zanyu Technology Co Ltd
SHE:002637
|
China | CN¥4.60 Billion |
|
Shanghai Aladdin Biochemical Technology Co. Ltd. A
SHG:688179
|
China | CN¥681.91 Million |
|
Build-A-Bear Workshop Inc
NYSE:BBW
|
USA | $175.88 Million |
|
Companhia de Saneamento do Paraná - SANEPAR
SA:SAPR3
|
Brazil | R$13.97 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Jiangxi Sanxin Medtec Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangxi Sanxin Medtec Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangxi Sanxin Medtec Co Ltd (2011–2024)
The table below shows the annual total liabilities of Jiangxi Sanxin Medtec Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥814.06 Million | +16.82% |
| 2023-12-31 | CN¥696.84 Million | +10.41% |
| 2022-12-31 | CN¥631.13 Million | +47.72% |
| 2021-12-31 | CN¥427.24 Million | +6.94% |
| 2020-12-31 | CN¥399.52 Million | -6.58% |
| 2019-12-31 | CN¥427.68 Million | +96.98% |
| 2018-12-31 | CN¥217.11 Million | +144.70% |
| 2017-12-31 | CN¥88.73 Million | +22.13% |
| 2016-12-31 | CN¥72.65 Million | +20.27% |
| 2015-12-31 | CN¥60.40 Million | -53.92% |
| 2014-12-31 | CN¥131.10 Million | +7.37% |
| 2013-12-31 | CN¥122.10 Million | +12.90% |
| 2012-12-31 | CN¥108.15 Million | +39.48% |
| 2011-12-31 | CN¥77.54 Million | -- |